IndraLab

Statements


| 1

sparser
"In the group of MSI tumours, low expression of KCNQ1 was not significantly associated with DFS in stage II colon cancer patients (HR 3.37; 95% CI 0.38–30.17; P =0.278; xref ), but was associated with poor DFS in stage III colon cancer patients (HR 5.06; 95% CI 1.07–23.89; P =0.041; xref )."